Barclays Expects M&A In Specialty Pharma To Continue, Likes Valeant And Jazz
July 09, 2015 at 08:56 AM EDT
In a report published Wednesday, Barclays analyst Douglas Tsao detailed why he believes that M&A activity within the Specialty ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.